{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:11:49Z","timestamp":1788970309639,"version":"build-2803163510"},"reference-count":30,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11479","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T09:06:11Z","timestamp":1585299971000},"source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency"],"prefix":"10.3892","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-4318","authenticated-orcid":false,"given":"Jinhuan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Yang","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"key20220302131334_b1-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1200\/JCO.1995.13.7.1800","article-title":"Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: A clinical review","volume":"13","author":"Byrd","year":"1995","journal-title":"J Clin Oncol"},{"key":"key20220302131334_b2-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/1097-0142(197306)31:6<1315::AID-CNCR2820310603>3.0.CO;2-C","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949\u20131969","volume":"31","author":"Liu","year":"1973","journal-title":"Cancer"},{"key":"key20220302131334_b3-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"key":"key20220302131334_b4-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1182\/blood.V35.3.361.361","article-title":"Granulocytic sarcoma (chloroma)","volume":"35","author":"Wiernik","year":"1970","journal-title":"Blood"},{"key":"key20220302131334_b5-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/1097-0142(197909)44:3<1017::AID-CNCR2820440333>3.0.CO;2-I","article-title":"Granulocytic sarcoma preceding acute leukemia: A report of six cases","volume":"44","author":"Krause","year":"1979","journal-title":"Cancer"},{"key":"key20220302131334_b6-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1182\/blood-2013-02-451757","article-title":"The myelodysplastic syndrome as a prototypical epigenetic disease","volume":"121","author":"Issa","year":"2013","journal-title":"Blood"},{"key":"key20220302131334_b7-ol-0-0-11479","first-page":"44","article-title":"Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemia","volume":"2","author":"Mohammadiasl","year":"2016","journal-title":"J Cancer Metastasis Treat"},{"key":"key20220302131334_b8-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ijc.28012","article-title":"Is acute myeloid leukemia a liquid tumor?","volume":"133","author":"Ohanian","year":"2013","journal-title":"Int J Cancer"},{"key":"key20220302131334_b9-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","article-title":"Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia","volume":"11","author":"Tallman","year":"1993","journal-title":"J Clin Oncol"},{"key":"key20220302131334_b10-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/sj.thj.6200336","article-title":"Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: Case report and review of the literature","volume":"5","author":"Sugimoto","year":"2004","journal-title":"Hematol J"},{"key":"key20220302131334_b11-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s13277-012-0589-7","article-title":"Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infltration by MMP-2","volume":"34","author":"Jiang","year":"2013","journal-title":"Tumour Biol"},{"key":"key20220302131334_b12-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.leukres.2014.05.004","article-title":"Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: Characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays","volume":"38","author":"Mirza","year":"2014","journal-title":"Leuk Res"},{"key":"key20220302131334_b13-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.leukres.2012.04.009","article-title":"Erythroblastic sarcoma","volume":"36","author":"Riddle","year":"2012","journal-title":"Leuk Res"},{"key":"key20220302131334_b14-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"key":"key20220302131334_b15-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40266-013-0084-x","article-title":"Decitabine: A review of its use in older patients with acute myeloid leukaemia","volume":"30","author":"Curran","year":"2013","journal-title":"Drugs Aging"},{"key":"key20220302131334_b16-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.15252\/embj.201488290","article-title":"Playing TETris with DNA modifcations","volume":"33","author":"Delatte","year":"2014","journal-title":"EMBO J"},{"key":"key20220302131334_b17-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/leu.2013.337","article-title":"The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases","volume":"28","author":"Solary","year":"2014","journal-title":"Leukemia"},{"key":"key20220302131334_b18-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/leu.2009.59","article-title":"Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"key20220302131334_b19-ol-0-0-11479","first-page":"13630","article-title":"Assessment of PET\/CT in multifocal myeloid sarcomas with loss of TET2: A case report and literature review","volume":"8","author":"Pan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20220302131334_b20-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"key":"key20220302131334_b21-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"key":"key20220302131334_b22-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20220302131334_b23-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1182\/blood-2006-03-009746","article-title":"International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"key":"key20220302131334_b24-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"key20220302131334_b25-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1182\/blood.V100.1.246","article-title":"Bethesda proposals for classification of lymphoid neoplasms in mice","volume":"100","author":"Morse","year":"2002","journal-title":"Blood"},{"key":"key20220302131334_b26-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V100.1.238","article-title":"Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice","volume":"100","author":"Kogan","year":"2002","journal-title":"Blood"},{"key":"key20220302131334_b27-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"15102","DOI":"10.1038\/ncomms15102","article-title":"Tet2 loss leads to hypermutagenicity in haematopoietic stem\/progenitor cells","volume":"8","author":"Pan","year":"2017","journal-title":"Nat Commun"},{"key":"key20220302131334_b28-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12185-018-2470-y","article-title":"Activity of decitabine in pericardial myeloid sarcoma","volume":"108","author":"Evers","year":"2018","journal-title":"Int J Hematol"},{"key":"key20220302131334_b29-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00277-016-2870-0","article-title":"Evidence for a role of decitabine in the treatment of myeloid sarcoma","volume":"96","author":"Gornicec","year":"2017","journal-title":"Ann Hematol"},{"key":"key20220302131334_b30-ol-0-0-11479","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.leukres.2010.01.009","article-title":"Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: Case report and review of literature","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:13:42Z","timestamp":1646219622000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11479","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]}}}